Differential pathogenesis of cowpox virus intranasal infections in mice induced by low and high inoculum volumes and effects of cidofovir treatment
- 21 February 2008
- journal article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 31 (4) , 352-359
- https://doi.org/10.1016/j.ijantimicag.2007.11.013
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Cell line dependency for antiviral activity and in vivo efficacy of N-methanocarbathymidine against orthopoxvirus infections in miceAntiviral Research, 2007
- Effects of cidofovir treatment on cytokine induction in murine models of cowpox and vaccinia virus infectionAntiviral Research, 2006
- The role of cytokines in the immune response to influenza A virus infection.2006
- Exotic emerging viral diseases: progress and challengesNature Medicine, 2004
- Oral Treatment of Cowpox and Vaccinia Virus Infections in Mice with Ether Lipid Esters of CidofovirAntimicrobial Agents and Chemotherapy, 2004
- Efficacy of Multiple- or Single-Dose Cidofovir against Vaccinia and Cowpox Virus Infections in MiceAntimicrobial Agents and Chemotherapy, 2003
- Characterization of Wild-Type and Cidofovir-Resistant Strains of Camelpox, Cowpox, Monkeypox, and Vaccinia VirusesAntimicrobial Agents and Chemotherapy, 2002
- Cidofovir Protects Mice against Lethal Aerosol or Intranasal Cowpox Virus ChallengeThe Journal of Infectious Diseases, 2000
- Pharmacokinetics, safety and bioavailability of HPMPC (cidofovir) in human immunodeficiency virus-infected subjectsAntiviral Research, 1996
- Efficacy of (S)‐1‐(3‐hydroxy‐2‐phosphonylmethoxypropyl)cytosine for the treatment of lethal vaccinia virus infections in severe combined immune deficiency (SCID) miceJournal of Medical Virology, 1993